secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001493152-23-016290
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma amends Alto warrant, secures $1.5M cash collateral, and receives new patent
--------------------------------------------------------------------------------

- Amended Alto warrant to remove anti-dilution adjustment; obtained shareholder approval for up to $10M additional convertible notes and warrants.
- Alto releases $1.5M cash collateral: $1M immediately, $500K upon filing Schedule 14C.
- U.S. Patent No. 11,654,157 approved for cancer therapy combining halogenated thymidines, thymidine phosphorylase inhibitors, and radiation; issuance May 23, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315223016290/0001493152-23-016290-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315223016290/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-016290

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer